Dr. Rebecca L Aft, M.D., Ph.D.
Claim this profileWashington University School of Medicine
Area of expertise
Breast Cancer
Rebecca L Aft, M.D., Ph.D. has run 8 trials for Breast Cancer. Some of their research focus areas include:
Ductal Carcinoma In Situ
Rebecca L Aft, M.D., Ph.D. has run 3 trials for Ductal Carcinoma In Situ. Some of their research focus areas include:
Affiliated Hospitals
Washington University School Of Medicine
Washington University St. Louis
Clinical Trials Rebecca L Aft, M.D., Ph.D. is currently running
SRG-514
for Breast Cancer
This is a multicenter, first-in-human (FIH), open label, Phase 1 dose escalation and recommended Phase 2 dose (RP2D) extension trial with a primary objective to define the RP2D of SRG-514 when administered intraoperatively to patients undergoing breast-conserving cancer surgery. SRG-514 will be investigated utilizing a 3+3 convention dose escalation cohorts.
Recruiting
1 award
Phase 1
3 criteria
Endocrine Therapy
for Low-Risk Breast Cancer
This trial is testing if hormone therapy alone can effectively treat breast cancer in women aged 70 or older with certain types of tumors. The therapy works by blocking estrogen, which helps stop cancer cells from growing. Researchers believe this approach could be enough to control the cancer without needing more aggressive treatments.
Recruiting
1 award
Phase 2
7 criteria
More about Rebecca L Aft, M.D., Ph.D.
Clinical Trial Related
1 year of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Rebecca L Aft, M.D., Ph.D. has experience with
- Anastrozole
- Exemestane
- Fulvestrant
- Goserelin
- Tamoxifen
- LS301
Breakdown of trials Rebecca L Aft, M.D., Ph.D. has run
Breast Cancer
Ductal Carcinoma In Situ
Ductal Carcinoma
Breast Disorder
Breast Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rebecca L Aft, M.D., Ph.D. specialize in?
Rebecca L Aft, M.D., Ph.D. focuses on Breast Cancer and Ductal Carcinoma In Situ. In particular, much of their work with Breast Cancer has involved HER2 negative patients, or patients who are Stage II.
Is Rebecca L Aft, M.D., Ph.D. currently recruiting for clinical trials?
Yes, Rebecca L Aft, M.D., Ph.D. is currently recruiting for 3 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Rebecca L Aft, M.D., Ph.D. has studied deeply?
Yes, Rebecca L Aft, M.D., Ph.D. has studied treatments such as Anastrozole, Exemestane, Fulvestrant.
What is the best way to schedule an appointment with Rebecca L Aft, M.D., Ph.D.?
Apply for one of the trials that Rebecca L Aft, M.D., Ph.D. is conducting.
What is the office address of Rebecca L Aft, M.D., Ph.D.?
The office of Rebecca L Aft, M.D., Ph.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.